Data / Research funding / New York / New York Medical College
New York Medical College: 41 NIH awards ($31.4M), fiscal years 2021 to 2026
New York Medical College in Valhalla, NY is funded under 41 NIH awards ($31.4M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- WK63UJ11C2H7
- State
- New York
Awards
41 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Role of Kir4.1 in regulating NCC and ROMK in DCT | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,644,972 | September 1, 2022 | April 30, 2027 | WANG, WENHUI | reporter.nih.gov |
| Regulation of Vascular Smooth Muscle Cell Phenotype by a Novel Isoform of Glucose-6-Phosphate Dehydrogenase | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,070,589 | December 15, 2022 | November 30, 2026 | GUPTE, SACHIN A | reporter.nih.gov |
| Regulation of NKCC2 isoforms and blood pressure by tumor necrosis factor-alpha | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,830,285 | September 1, 2021 | August 31, 2025 | FERRERI, NICHOLAS R | reporter.nih.gov |
| GPR75 in obesity-driven cardiovascular and metabolic complications | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,690,170 | April 1, 2023 | February 28, 2027 | SCHWARTZMAN, MICHAL LANIADO | reporter.nih.gov |
| Cannabinoid modulation of EV composition and function in HIV/SIV infection | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,560,682 | August 1, 2022 | July 31, 2025 | OKEOMA, CHIOMA M | reporter.nih.gov |
| Common schizophrenia variants functioning in developmental human cortical interneurons | NIH | National Institute of Mental Health | 2023 to 2024 | $1,324,075 | July 1, 2023 | August 29, 2024 | CHUNG, SANGMI | reporter.nih.gov |
| Roles of heat shock transcriptional factor 1 in cell proliferation independent of the heat shock response | NIH | National Institute of General Medical Sciences | 2022 to 2024 | $1,274,943 | September 2, 2020 | August 31, 2025 | LI, JIAN | reporter.nih.gov |
| NOX4-associated oxidative stress mediates vascular and kidney impairment in the low birth weight adult | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,230,000 | December 15, 2019 | November 30, 2025 | RATLIFF, BRIAN BLAKE | reporter.nih.gov |
| Protective antibody in streptococcal infection models | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $1,193,428 | December 2, 2022 | November 30, 2028 | BESSEN, DEBRA E | reporter.nih.gov |
| Brain-region-specific humanized cortical interneuron mice | NIH | National Institute of Mental Health | 2023 to 2024 | $1,102,988 | July 1, 2023 | August 29, 2024 | CHUNG, SANGMI | reporter.nih.gov |
| Glycocalyx repair in sepsis using liposomal carriers of preassembled glycocalyx | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,082,400 | August 5, 2019 | June 30, 2024 | GOLIGORSKY, MICHAEL S | reporter.nih.gov |
| Regulation of Kir4.1/Kir5.1 and renal potassium excretion | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,067,968 | July 26, 2023 | June 30, 2027 | LIN, DAO-HONG | reporter.nih.gov |
| Neural mechanisms of ultrasound-induced enhancement of sensory acuity | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2023 | $1,015,558 | April 1, 2020 | December 31, 2024 | FISHER, JONATHAN A.N. | reporter.nih.gov |
| Synaptic Modulation of Mesopontine Cholinergic Neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $962,548 | December 1, 1991 | June 30, 2025 | LEONARD, CHRISTOPHER S | reporter.nih.gov |
| Estrogenic signaling upstream and downstream of mTOR | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $880,134 | September 1, 2018 | August 31, 2025 | HOLZ, MARINA K | reporter.nih.gov |
| Characterizing the physicochemical properties of membraneless condensates and its regulation by delta-9-tetrahydrocannabinol in HIV/SIV infection. | NIH | National Institute on Drug Abuse | 2023 to 2024 | $877,149 | April 15, 2021 | July 31, 2026 | OKEOMA, CHIOMA M | reporter.nih.gov |
| Hypertension and inflammation: novel insights from human angiotensin type 1 receptor variants | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $820,000 | April 1, 2019 | July 31, 2024 | JAIN, SUDHIR | reporter.nih.gov |
| Myocyte Repolarization and Cardiac Dysfunction with Age | NIH | National Institute on Aging | 2021 to 2022 | $808,198 | August 1, 2018 | April 30, 2024 | ROTA, MARCELLO | reporter.nih.gov |
| Sensory Neuromodulation of Pancreatic Beta Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $803,600 | August 1, 2023 | June 30, 2026 | EL OUAAMARI, ABDELFATTAH | reporter.nih.gov |
| Mechanism of Chemoreflex and Baroreflex alterations causing Postural Tachycardia Syndrome in POTS patients with orthostatic hyperpnea and hypocapnia. | NIH | National Heart, Lung, and Blood Institute | 2022 | $708,618 | September 23, 2022 | August 31, 2024 | MEDOW, MARVIN S | reporter.nih.gov |
| Molecular Mechanisms of 20-HETE-mediated Vascular Dysfunction and Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 | $570,314 | December 1, 2017 | May 31, 2023 | SCHWARTZMAN, MICHAL LANIADO | reporter.nih.gov |
| Stem Cell-Derived Developmental Human Cortical Interneurons to Treat Intractable Epilepsy | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $565,775 | May 1, 2021 | April 30, 2024 | CHUNG, SANGMI | reporter.nih.gov |
| Macrolide resistance transfer in Streptococcus pyogenes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $461,347 | August 24, 2021 | July 31, 2025 | BESSEN, DEBRA E | reporter.nih.gov |
| Targeting EBV's Deubiquitinating Activity for Therapy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $453,750 | July 17, 2024 | May 31, 2027 | WHITEHURST, CHRISTOPHER BENTON | reporter.nih.gov |
| The role of DNA Polymerase Delta 4 in Lung Carcinogenesis Induced by Genotoxic Carcinogens | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $453,698 | June 18, 2024 | May 31, 2027 | XU, DAZHONG | reporter.nih.gov |
| Systematic search for novel treatments of infantile spasms among sigma-1 receptor ligands | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $451,000 | April 1, 2021 | September 30, 2023 | VELISEK, LIBOR | reporter.nih.gov |
| A Novel Mucosal Vaccine for Pseudomonas aeruginosa Infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $444,989 | February 1, 2022 | July 31, 2024 | ARNABOLDI, PAUL MICHAEL | reporter.nih.gov |
| High Resolution Functional Maps of Enhancer RNA and Subcellular RNA Granules in Human Immune Cells | NIH | National Institute of General Medical Sciences | 2025 | $407,440 | January 15, 2025 | May 31, 2027 | KWAK, HOJOONG | reporter.nih.gov |
| Role of SIN3a in the epigenetic regulation of the Bone Morphogenetic Protein Receptor Type 2 in pulmonary arterial hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $405,909 | September 1, 2022 | August 31, 2025 | BISSERIER, MALIK | reporter.nih.gov |
| Modeling Lennox-Gastaut Syndrome for improved clinical and neurobehavioral outcomes | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $396,804 | August 1, 2025 | July 31, 2026 | VELISEK, LIBOR | reporter.nih.gov |
| Kir5.1 regulates Kir4.1 ubiquitination by Nedd4-2 in DCT | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $369,000 | December 25, 2017 | November 30, 2022 | LIN, DAO-HONG | reporter.nih.gov |
| Tobacco Mosaic Virus as a mucosal delivery platform for an intranasal vaccine against Pseudomonas aeruginosa | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $261,846 | July 2, 2025 | June 30, 2027 | ARNABOLDI, PAUL MICHAEL | reporter.nih.gov |
| Characterizing the physicochemical properties of membraneless condensates and its regulation by delta-9-tetrahydrocannabinol in HIV/SIV infection. | NIH | National Institute on Drug Abuse | 2022 | $218,020 | April 15, 2021 | July 31, 2023 | OKEOMA, CHIOMA M | reporter.nih.gov |
| Advancement of a Mucosal Subunit Vaccine in an Outbred Model of Respiratory Tularemia | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $195,082 | February 18, 2020 | July 31, 2023 | BAKSHI, CHANDRA SHEKHAR | reporter.nih.gov |
| Characterization of Francisella tularensis-specific bacteriophages | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $176,875 | April 1, 2021 | March 31, 2024 | BAKSHI, CHANDRA SHEKHAR | reporter.nih.gov |
| Uncovering the role of GPR75 as an activator of fatty acid transporters in non-alcoholic fatty liver disease (NAFLD) | NIH | National Center for Advancing Translational Sciences | 2023 | $164,000 | July 1, 2023 | December 31, 2024 | GARCIA, VICTOR | reporter.nih.gov |
| Treatment Planning System for Electron FLASH radiation therapy | NIH | National Cancer Institute | 2024 | $162,770 | February 6, 2024 | September 27, 2024 | ZHANG, RONGXIAO | reporter.nih.gov |
| Role of Kir4.1 in Regulating NCC and ROMK in DCT | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $100,001 | March 1, 2001 | August 31, 2022 | WANG, WENHUI | reporter.nih.gov |
| ProteinSimple Jess System for Protein Analysis at NYMC | NIH | Office of the Director, National Institutes of Health | 2024 | $97,364 | May 15, 2024 | May 14, 2025 | OKEOMA, CHIOMA M | reporter.nih.gov |
| Pilin Genotyping for Group A Streptococci | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $77,981 | June 1, 2020 | May 31, 2023 | BESSEN, DEBRA E | reporter.nih.gov |
| Seventh International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma | NIH | National Cancer Institute | 2022 | $4,475 | September 7, 2022 | August 31, 2023 | CAIRO, MITCHELL S. | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 9 | $3,801,152 | 0 | $0 |
| 2024 | 16 | $6,352,598 | 0 | $0 |
| 2023 | 17 | $8,210,969 | 0 | $0 |
| 2022 | 18 | $6,876,442 | 0 | $0 |
| 2021 | 17 | $6,145,584 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 8 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 8 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 8 awards here |
Topics of its NIH awards
- Genetics
- Infectious Diseases
- Rare Diseases
- Neurosciences
- Biotechnology
- Cardiovascular
- Prevention
- Orphan Drug
- Kidney Disease
- Nutrition
- Emerging Infectious Diseases
- Hypertension
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.